Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Drove Alpha Modus Amod Stock Higher This Week Price At 0.35 Down 1.72 20260407 Is Bj S Rest Bjri Stock Good For Passive Investors Bjri Q4 2025 Earnings Bj S Restaurants Inc. Tops Consensus Eps With 0.66 Actual Figure 20260408 Is Cabot Cbt Stock Showing Weakness Cbt Q4 Earnings Beats Estimates By 0.11 20260408 1 Lifetime Brands LCUT Surges 382 Nearing 799 Resistance 20260518 Historic Fed Overlap Powell and Warsh Set for First Joint FOMC Meeting in June Aktis AKTS Fell 361 Is a Recovery Ahead 20260518 DWave Quantum Stock Between Science Fiction and Financial Reality SpaceX Delays Starship Launch Amid Potential RecordBreaking IPO Plans The US 10Year Bond Yield A Critical Driver of Global Financial Markets Rupee Strengthens for Third Session on Oil Slump and RBI Support Closes at 9523 per Dollar Micron Technology Stock Surges on UBS Bullish Outlook and Strong Memory Chip Demand Puig Shares Plunge as Este Lauder TieUp Talks Collapse European Markets Edge Higher Perpetua Resources Secures 29 Billion US Government Loan for Idaho Critical Minerals Project NGS Q1 2026 Earnings EPS Surprises to the Upside Amidst Solid Operational Execution Kelly Services Inc KELYA Q1 2026 Earnings EPS Misses Estimates by 60 Stock Rises Slightly TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline Century Communities Q1 2026 Earnings Strong EPS Beat Amid Housing Market Headwinds KMT Q1 2026 Earnings Earnings Beat Estimates by 1345 Shares Edge Higher SBFM Q1 2026 Earnings PreRevenue Biotech Reports Net Loss of 025 Per Share Stock Falls 25 Bunge BG Slips Slightly as Trading Activity Reflects Cautious Sentiment Verastem VSTM Declines 25 as Biotech Sector Headwinds Persist REalloys Inc ALOY Rallies 285 Approaches Key Resistance Level Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance Colony Bankcorp CBAN Shows Modest Gains as Stock Tests Key Resistance Zone